The emergence of ketamine-previously known as a combat anesthetic and club drug-as a treatment for depression. Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years-in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug-that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader. | Ketamine by Bita Moghaddam, Paperback | Indigo Chapters